Afsaneh was Vice President, Product Development Team Leader, Rare Genetic Diseases at Agios Pharmaceuticals, and Head of Program and Alliance Management at Bind Therapeutics. Afsaneh Mohebbi joined PepGen in 2024.
Afsaneh Mohebbi is currently
Create your alert
to follow the career of Afsaneh Mohebbi.
Afsaneh Mohebbi has a PhD in Physical Chemistry of NMR Spectroscopy from University Of California, Irvine .
They have also studied at University Of California, Irvine :
Find more alumni from University Of California, Irvine
Do you need to know more about Afsaneh Mohebbi? More results.
Report an error
Update the org chart details of Afsaneh Mohebbi.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.